Raiffeisen Bank International AG Acquires 675 Shares of Align Technology, Inc. $ALGN

Raiffeisen Bank International AG boosted its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 3.0% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,197 shares of the medical equipment provider’s stock after buying an additional 675 shares during the quarter. Raiffeisen Bank International AG’s holdings in Align Technology were worth $4,341,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently modified their holdings of ALGN. Signaturefd LLC boosted its stake in shares of Align Technology by 23.6% during the first quarter. Signaturefd LLC now owns 821 shares of the medical equipment provider’s stock valued at $130,000 after purchasing an additional 157 shares during the period. Apollon Wealth Management LLC bought a new position in Align Technology in the 1st quarter worth about $363,000. South Dakota Investment Council increased its position in shares of Align Technology by 38.3% during the first quarter. South Dakota Investment Council now owns 8,306 shares of the medical equipment provider’s stock worth $1,319,000 after acquiring an additional 2,300 shares during the period. Teachers Retirement System of The State of Kentucky increased its position in shares of Align Technology by 3.1% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 5,445 shares of the medical equipment provider’s stock worth $865,000 after acquiring an additional 166 shares during the period. Finally, Allianz Asset Management GmbH raised its stake in shares of Align Technology by 13.7% during the first quarter. Allianz Asset Management GmbH now owns 553,908 shares of the medical equipment provider’s stock valued at $88,000,000 after acquiring an additional 66,614 shares in the last quarter. Institutional investors own 88.43% of the company’s stock.

Align Technology Trading Down 3.3%

Shares of ALGN opened at $132.61 on Tuesday. The firm has a market cap of $9.51 billion, a PE ratio of 25.70, a P/E/G ratio of 1.49 and a beta of 1.84. Align Technology, Inc. has a 12 month low of $122.00 and a 12 month high of $246.19. The stock has a fifty day moving average price of $132.83 and a 200-day moving average price of $158.73.

Align Technology (NASDAQ:ALGN) last released its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 EPS for the quarter, beating analysts’ consensus estimates of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to analysts’ expectations of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The firm’s revenue was up 1.8% compared to the same quarter last year. During the same period last year, the business posted $2.35 earnings per share. Align Technology has set its Q4 2025 guidance at EPS. As a group, research analysts forecast that Align Technology, Inc. will post 7.98 EPS for the current year.

Align Technology announced that its board has approved a share buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to buy up to 2% of its shares through open market purchases. Shares buyback programs are usually a sign that the company’s leadership believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. UBS Group lowered their target price on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a report on Thursday, October 16th. Morgan Stanley increased their target price on shares of Align Technology from $142.00 to $154.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Leerink Partners boosted their price target on shares of Align Technology from $172.00 to $189.00 in a report on Thursday, October 30th. Jefferies Financial Group upped their price target on shares of Align Technology from $140.00 to $155.00 in a research report on Thursday, October 30th. Finally, Stifel Nicolaus set a $200.00 price objective on shares of Align Technology in a report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $175.45.

Align Technology Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.